SEC Filing Details

Document Details

Form
Filing Date
May 24, 2022
Document Date
Feb 14, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Kiromic BioPharma, Inc.
Issuer
KIROMIC BIOPHARMA, INC.
Filer
REEVES KAREN

Investor Tools

Print

RSS Feeds

Email Alerts

Investor Contact